OmegaQuant’s Omega-3 Index and Prenatal DHA test kits are now registered in the European Union as in vitro medical devices and CE-marked.
Photo © iStockphoto.com/Juxtagirl
OmegaQuant’s Omega-3 Index and Prenatal DHA test kits are now registered in the European Union as in vitro medical devices and CE-marked, demonstrating that it meets the essential requirements of all relevant European Medical Device Directives. This means that the kits now meet regulatory approval for sale in Europe. To carry out analysis of omega-3 test coming from European consumers, OmegaQuant has partnered with the Nutritional Analytical Service at the Institute of Aquaculture at the University of Stirling, in Scotland.
“We are partnering with the University of Stirling to run our testing methods in their laboratory,” explains Jason Polreis, CEO, OmegaQuant, in a press release. “This way we are offering the same accurate, precise, and scientifically validated methods at our three laboratories covering North America, Asia-Pacific, and now Europe.”
Having a dedicated lab in Europe allows OmegaQuant to deliver results in a timelier manner. “We are looking forward to bringing an at-home collection kit to the EU market to make access to the Omega-3 Index and Prenatal DHA tests convenient, so individuals can personalize their omega-3 intake,” adds Polreis.
Kratom sees impressive sales growth despite its regulatory status and stigma
March 12th 2025Despite its controversy, kratom is a top-selling ingredient that consumers see value in. That said, brands need to work hard to demonstrate safety and quality of kratom products in the absence of legal regulatory status. Will kratom be able to overcome its stigma for even more growth and consumer acceptance?
DOJ asks Utah court to dismiss FTC lawsuit against Xlear Inc.
March 11th 2025On March 10, the DOJ and the defendant filed a stipulation to dismiss with prejudice the lawsuit in which each party agrees “to be responsible for its own costs and fees and agrees that no party shall be responsible to any other party for any fines, costs, fees, or penalties arising from this case.”